ELUT
Elutia Inc Class A · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website elutia.com
- Employees(FY) 53
- ISIN US05479K1060
Performance
+15.26%
1W
+22.35%
1M
+7.35%
3M
+32.33%
6M
+102.78%
YTD
+170.37%
1Y
Profile
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. It offers CanGaroo Envelope, which is used for the stabilization of implantable cardiac devices, such as pacemakers and defibrillators. The company also engages in the development of CanGaroo RM for delivery directly to the surgical site. In addition, it offers SimpliDerm Acellular Dermal Matrix used primarily in breast reconstruction following mastectomy. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Technical Analysis of ELUT 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-14 03:05
- 2024-11-13 03:05
- 2024-11-12 18:27
What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings(Yahoo Finance)
- 2024-10-29 04:05
- 2024-10-23 04:05
- 2024-10-17 04:15
SWK Holdings Provides Portfolio Update(Accesswire)
- 2024-10-14 23:01
- 2024-09-17 20:00
- 2024-09-06 04:23
Elutia Celebrates First Year(Globenewswire)
- 2024-09-05 04:05
- 2024-09-03 04:05
Elutia to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-08-20 19:00
- 2024-08-19 19:00
- 2024-08-07 04:05
Elutia Announces Second Quarter 2024 Results(Yahoo Finance)
- 2024-08-01 04:05
- 2024-07-31 04:05
- 2024-07-30 04:05
- 2024-07-17 04:15
- 2024-07-16 19:00
- 2024-07-15 19:00
- 2024-07-11 04:05
- 2024-07-11 03:24
7 Growth Stocks to Buy for Under $5 for Massive Gains(Investorplace)
- 2024-06-16 20:01
Elutia Announces $13.26 Million Registered Direct Offering(Globenewswire)
- 2024-06-16 20:00
- 2024-05-12 20:00
- 2024-05-09 10:55
- 2024-05-09 04:05
- 2024-05-02 04:05
- 2024-04-28 21:00
- 2024-04-24 04:05
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.